BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 18181283)

  • 1. [Laboratory identification of monoclonal immunoglobin].
    Tichý M; Maisnar V
    Vnitr Lek; 2006 Nov; 52 Suppl 2():41-5. PubMed ID: 18181283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current role of the laboratory in the demonstration and follow up of monoclonal immunoglobulinopathy].
    Myara I
    Pathol Biol (Paris); 1990 Feb; 38(2):134-43. PubMed ID: 2107510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of free light chains--a new method of diagnostics of haematological diseases].
    Mecl J; Benáková H; Nohejlová A; Straub J; Zima T; Spicka I
    Cas Lek Cesk; 2007; 146(2):159-62. PubMed ID: 17373113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Monoclonal gammopathies: classification of laboratory tests].
    D'Angelo G; Giardini C; Calvano D; Braghini T
    Minerva Med; 1985 Oct; 76(41):1921-6. PubMed ID: 3932901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evolving use of serum free light chain assays in haematology.
    Pratt G
    Br J Haematol; 2008 May; 141(4):413-22. PubMed ID: 18318757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elimination of the need for urine studies in the screening algorithm for monoclonal gammopathies by using serum immunofixation and free light chain assays.
    Katzmann JA; Dispenzieri A; Kyle RA; Snyder MR; Plevak MF; Larson DR; Abraham RS; Lust JA; Melton LJ; Rajkumar SV
    Mayo Clin Proc; 2006 Dec; 81(12):1575-8. PubMed ID: 17165636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunoelectrophoresis or immunofixation: identification of monoclonal gammopathy].
    Vittu C; Forzy G; Macart M; Dhondt JL
    Ann Pharm Fr; 1991; 49(3):167-71. PubMed ID: 1929121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum free light chain assay reduces the need for serum and urine immunofixation electrophoresis in the evaluation of monoclonal gammopathy.
    Fulton RB; Fernando SL
    Ann Clin Biochem; 2009 Sep; 46(Pt 5):407-12. PubMed ID: 19641008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance evaluation of the Helena V8 capillary electrophoresis system.
    Poisson J; Fedoriw Y; Henderson MP; Hainsworth S; Tucker K; Uddin Z; McCudden CR
    Clin Biochem; 2012 Jun; 45(9):697-9. PubMed ID: 22465274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can serum free light chains replace urine electrophoresis in the detection of monoclonal gammopathies?
    Beetham R; Wassell J; Wallage MJ; Whiteway AJ; James JA
    Ann Clin Biochem; 2007 Nov; 44(Pt 6):516-22. PubMed ID: 17961305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Monoclonal gammopathies in a series of 1683 plasma donors].
    Tichý M; Rehácek V; Maisnar V; Dominiková K; Palicka V
    Cas Lek Cesk; 2004; 143(6):401-4; discussion 404. PubMed ID: 15309868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of capillary zone and immunosubtraction with agarose gel and immunofixation electrophoresis for detecting and identifying monoclonal gammopathies.
    Litwin CM; Anderson SK; Philipps G; Martins TB; Jaskowski TD; Hill HR
    Am J Clin Pathol; 1999 Sep; 112(3):411-7. PubMed ID: 10478148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening and Diagnosis of Monoclonal Gammopathies: An International Survey of Laboratory Practice.
    Genzen JR; Murray DL; Abel G; Meng QH; Baltaro RJ; Rhoads DD; Delgado JC; Souers RJ; Bashleben C; Keren DF; Ansari MQ
    Arch Pathol Lab Med; 2018 Apr; 142(4):507-515. PubMed ID: 29266967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The monoclonal gammopathies.
    Kyle RA
    Clin Chem; 1994 Nov; 40(11 Pt 2):2154-61. PubMed ID: 7955402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum and Urine Protein Electrophoresis and Serum-Free Light Chain Assays in the Diagnosis and Monitoring of Monoclonal Gammopathies.
    Singh G
    J Appl Lab Med; 2020 Nov; 5(6):1358-1371. PubMed ID: 33150391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Urinary investigations in the diagnosis and monitoring of monoclonal gammopathies in daily practice].
    Oudart JB; Quinquenel A; Lavalard E; Schneider N; Fromonot J; Ramont L; Maquart FX
    Ann Biol Clin (Paris); 2014; 72(2):147-52. PubMed ID: 24736135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Algorithm management for detection of monoclonal gammopathies in serum. Experience of the Instituto Nacional de Cancerología in México].
    Guarner J; Ramírez EC; Sobrevilla P
    Rev Med Chil; 1995 Dec; 123(12):1499-504. PubMed ID: 8733267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefits of new immunoglobulin-derived biomarkers for the diagnosis and follow-up of patients with dysglobulinemia.
    Ermak N; Nguyen-Khoa T; Alyanakian MA
    Ann Biol Clin (Paris); 2016 Oct; 74(5):597-605. PubMed ID: 27707674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coagulation disorders in patients with monoclonal gammopathies.
    Keren DF
    Hematol Oncol Clin North Am; 1993 Dec; 7(6):1153-9. PubMed ID: 8294313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of the Sebia CAPILLARYS 2 for detection and immunotyping of serum monoclonal paraproteins.
    Yang Z; Harrison K; Park YA; Chaffin CH; Thigpen B; Easley PL; Smith JA; Robinson CA; Lorenz RG; Hardy RW
    Am J Clin Pathol; 2007 Aug; 128(2):293-9. PubMed ID: 17638665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.